Fosinopril formulation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 16, 2006
Grant Date -
Nov 17, 2005
app pub date -
Mar 19, 2003
filing date -
Mar 19, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A pharmaceutical formulation is provided comprising fosinopril which is the prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. The formulation is characterized by comprising in the range of about 0.25 to about 5% glyceryl dibehenate which has been found to be a highly useful lubricant in the manufacture of tablets according to the present invention, enhancing the stability of fosinopril as compared to prior art formulations.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully